Overview of General and Discriminating Markers of Differential Microglia Phenotypes.

Jurga AM, Paleczna M, Kuter KZ. · 2020

Read Overview of General and Discriminating Markers of Differential Microglia Phenotypes. by Jurga AM, Paleczna M, Kuter KZ. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7424058.txt.

Introduction

Jurga and co-authors gather what is known about markers that identify microglia, the resident immune cells of the brain. These cells shift shape and role as brain conditions change. Picking the right marker is key to telling one cell state from another.

The review sorts markers by type: general and specific, on the cell surface or inside it, and some that cells release. It shows how to tell true microglia from macrophages that enter from the blood. It also covers active states, from harmful M1-like cells to healing M2-like cells. Human and rodent markers differ, which adds care to study design. The guide helps labs choose markers for work on brain inflammation and disease.

Catalog record

CREATORJurga AM, Paleczna M, Kuter KZ.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE92 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7424058

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Overview of General and Discriminating Markers of Differential Microglia Phenotypes By Agnieszka M Jurga, Martyna Paleczna, Katarzyna Z Kuter Published in: Frontiers in Cellular Neuroscience DOI: 10.3389/fncel.2020.00198 ABSTRACT Abstract Inflammatory processes and microglia activation accompany most of the pathophysiological diseases in the central nervous system. It is proven that glial pathology precedes and even drives the development of multiple neurodegenerative conditions. A growing number of studies point out the importance of microglia in brain development as well as in physiological functioning. These resident brain immune cells are divergent from the peripherally infiltrated macrophages, but their precise in situ discrimination is surprisingly difficult. Microglial heterogeneity in the brain is especially visible in their morphology and cell density in particular brain structures but also in the expression of cellular markers. This often determines their role in physiology or pathology of brain functioning. The species differences between rodent and human markers add complexity to the whole picture. Furthermore, due to activation, microglia show a broad spectrum of phenotypes ranging from the pro-inflammatory, potentially cytotoxic M1 to the anti-inflammatory, scavenging, and regenerative M2. A precise distinction of specific phenotypes is nowadays essential to study microglial functions and tissue state in such a quickly changing environment. Due to the overwhelming amount of data on multiple sets of markers that is available for such studies, the choice of appropriate markers is a scientific challenge. This review gathers, classifies, and describes known and recently discovered protein markers expressed by microglial cells in their different phenotypes. The presented microglia markers include qualitative and semi-quantitative, general and specific, surface and intracellular proteins, as well as secreted molecules. The information provided here creates a comprehensive and practical guide through the current knowledge and will facilitate the choosing of proper, more specific markers for detailed studies on microglia and neuroinflammatory mechanisms in various physiological as well as pathological conditions. Both basic research and clinical medicine need clearly described and validated molecular markers of microglia phenotype, which are essential in diagnostics, treatment, and prevention of diseases engaging glia activation. Keywords: microglial heterogeneity, infiltrating macrophages, inflammation, polarization, M1/M2 phenotype, neurotoxicity, regeneration INTRODUCTION Why are cells previously considered as merely “brain glue” now gaining such a tremendous amount of interest? Microglia were, for a long time, considered to have potentially deleterious functions, but further studies showed that they can act both in a cytotoxic and in a neuroregenerative way depending on their current phenotype. Central nervous system (CNS) microglial cells show a complex set of phenotypes dynamically changing in physiology and pathology. Therefore, it is essential to precisely recognize their activation states and functions via specific markers. In this review, we will focus on microglial heterogeneity. We will describe its general markers, including those selectively discriminating microglia from peripheral macrophages, as well as indicators of activation and of particular phenotypes. Qualitative markers vs. semi-quantitative expression of different protein ratios will also be shown here. The importance of accurate microglial phenotype description is depicted via examples of inflammatory processes in the aging brain, as well as in diseases and their diagnostics. Shifting between microglial phenotypes has recently become a therapeutic approach in multiple CNS diseases. Definite description of microglia profiles is an important challenge in today’s drug design studies. The information gathered here will be helpful in choosing the appropriate descriptors or targets for studies and will allow more precise identification of microglial states in research while defining immunological mechanisms in the brain. THE NATURE OF MICROGLIA, THEIR ROLE, AND THEIR FUNCTION IN THE BRAIN Microglial cells are the resident macrophages of CNS and account for about 10% of the cell population, with a mean density of ca. 70 cells/mm2 in mouse brain tissue. The estimated number of microglial cells in the CNS reaches 3.5 million (Lawson et al., 1990). The other source of immunocompetent cells in the brain are the macrophages infiltrating from the periphery (Daneman et al., 2010). Ontogenetically, the microglial population differentiates from the embryonic yolk sac, while peripheral macrophages are the monocytes originating from the hematopoietic stem cells and maturating in bone marrow (Gomez Perdiguero et al., 2013; Figure 1). For the purposes of this review, the resident CNS macrophage population will be referred to as microglia and peripherally originating monocytes will be called macrophages. In contrast to neurons, microglial cells have the ability to completely restore their population in the adult brain. According to recent rodent studies, less than 1% of the microglial population was able to completely restore the original density in 1 week (Elmore et al., 2015). The human microglial population renews at a rate of ca. 28% per year, meaning that a microglial cell is approx. 4.2 years old (Réu et al., 2017). [Figure: Differences and similarities between resident microglia and peripheral macrophage ontogeny and markers.] In the developing brain, microglia function to shape and protect the environment. They take part in synaptic remodeling, pruning, vessel patterning, and angiogenesis promotion (Du et al., 2017). The general functions of microglia in the adult brain are to monitor the environment and to start an inflammatory response in case of the detection of any danger signal. They are the first line of defense in the brain. Microglia can recognize pathogens and subtle changes in the microenvironment with surface receptors that detect complement fragments, immunoglobulins, adhesion molecules, chemokine receptors (CCR), Toll-like receptors (TLR), purinoceptors, and scavenger and Fc receptors. When any potential danger is recognized, microglia become activated and communicate by cytokine release, which alerts surrounding cells and influences their functioning. This triggers an inflammatory state, a physiological condition that is strictly regulated and silenced over time. If neuronal malfunction is detected, microglia are also responsible for introducing cellular death (Wake et al., 2009; Hornik et al., 2016). This may be triggered via microglial NMDA receptor activation and consequent inducible nitric oxide synthase (iNOS) upregulation and secretion of multiple inflammatory and cytotoxic factors (Kaindl et al., 2012). When inflammation is very strong or its regulation fails and the pro-inflammatory phase is prolonged, it can be harmful to the tissue environment, and microglia can even kill healthy neurons (Brown and Vilalta, 2015; Gomes-Leal, 2019). Cellular debris and cytotoxic protein aggregates released by other cells can also be phagocytosed by microglia, cleaning the extracellular space (Neumann et al., 2009; Herzog et al., 2019). Importantly, microglia also have protective functions. They release anti-inflammatory cytokines, silencing the local inflammation, produce mediators of myelin repair, participating in axonal regeneration and neurogenesis, and also promote trophic support by secretion of neurotrophins (Gomes-Leal, 2012). GENERAL MICROGLIA MARKERS When choosing microglia markers for visualization, their localization is of the essence. Microglia markers include surface, intracellular (cytosolic proteins, gene transcripts), and released molecules. The general microglia markers can be detected irrespective of current cell phenotype. The most widely used markers are ionized calcium-binding adapter molecule 1 (IBA-1; Yun et al., 2018), cluster of differentiation receptors (CD68, CD11b, CD14, CD45, CD80, and CD115; Zanoni et al., 2011; Fadini et al., 2013; Jenkins et al., 2013; Jeong et al., 2013; Rice et al., 2017), fractalkine receptor (CX3CR1; Jones et al., 2010), ferritin (Holland et al., 2018), F4/80 (Lin et al., 2005), high-affinity immunoglobulin epsilon receptor subunit gamma (FCER1G) and vimentin (Lebedeva et al., 2005; Mukherjee et al., 2016). Many of those markers

Read the complete text